Why the study?
What are the mechanisms, laboratory evaluation, clinical impact, and management of resistance to aspirin and clopidogrel therapy?
What are the mechanisms, laboratory evaluation, clinical impact, and management of resistance to aspirin and clopidogrel therapy?
This review highlights the clinical challenge of aspirin and clopidogrel resistance, emphasizing the need for better understanding of mechanisms and optimal management strategies.
No takes yet. Share an insight, caveat, or question.
May complicate antiplatelet therapy in high-risk patients; leaves open standardized testing and evidence-based management strategies.
Musallam et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: